SeQual Technologies

SeQual Technologies, established in 1991, specializes in the development and manufacturing of medical oxygen concentrators and air separation systems. In December 2010, the company was acquired by Chart Industries through its subsidiary, CAIRE Inc., a move that integrated SeQual's portable oxygen technology into Chart's broader respiratory care portfolio. The acquisition involved an initial payment of approximately $40 million.

The company's business is centered on providing devices that separate oxygen from the ambient air, offering supplemental breathing oxygen for individuals with chronic respiratory conditions. Beyond the medical field, SeQual's technology also serves military, industrial, and commercial applications. Its clients are primarily in the home healthcare market, but also extend to other sectors requiring air separation systems. Revenue is generated through the sale of these devices and systems.

SeQual's core product line revolves around its proprietary pressure swing adsorption (PSA) technology. A key component is the Advanced Technology Fractionator (ATF) module, a device that efficiently separates oxygen from the air, allowing for the creation of lightweight and compact oxygen concentrators. Notable products include the Eclipse 5 and eQuinox portable oxygen concentrators, which offer both continuous flow and pulse dose options, enabling them to be used 24/7, both at home and while mobile. The company also produces high-capacity bedside units like the Integra, which can deliver up to 10 liters per minute.

Keywords: medical oxygen concentrators, air separation systems, pressure swing adsorption, portable oxygen technology, respiratory care, therapeutic devices, chronic lung disease, home healthcare, continuous flow oxygen, pulse dose oxygen, CAIRE Inc., Chart Industries, Eclipse 5, eQuinox, medical devices, oxygen therapy, supplemental oxygen, ATF module, non-delivery oxygen